Notice: This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends LLIT vs. AEMD, STSS, INBS, AFIB, INVO, VERO, RSLS, TNON, AVGR, and DYNTShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Aethlon Medical (AEMD), Sharps Technology (STSS), Intelligent Bio Solutions (INBS), Acutus Medical (AFIB), INVO Bioscience (INVO), Venus Concept (VERO), ReShape Lifesciences (RSLS), Tenon Medical (TNON), Avinger (AVGR), and Dynatronics (DYNT). These companies are all part of the "medical" sector. Lianluo Smart vs. Aethlon Medical Sharps Technology Intelligent Bio Solutions Acutus Medical INVO Bioscience Venus Concept ReShape Lifesciences Tenon Medical Avinger Dynatronics Lianluo Smart (NASDAQ:LLIT) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, community ranking, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Does the media refer more to LLIT or AEMD? In the previous week, Aethlon Medical's average media sentiment score of 0.50 beat Lianluo Smart's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Overall Sentiment Lianluo Smart Neutral Aethlon Medical Positive Which has more volatility and risk, LLIT or AEMD? Lianluo Smart has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Do analysts prefer LLIT or AEMD? Aethlon Medical has a consensus price target of $7.00, indicating a potential upside of 1,719.95%. Given Aethlon Medical's higher probable upside, analysts clearly believe Aethlon Medical is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, LLIT or AEMD? Lianluo Smart has higher earnings, but lower revenue than Aethlon Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K3.60-$4.45MN/AN/AAethlon Medical$570K9.41-$12.21M-$3.84-0.10 Does the MarketBeat Community prefer LLIT or AEMD? Aethlon Medical received 113 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 52.42% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformLianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% Aethlon MedicalOutperform Votes21752.42% Underperform Votes19747.58% Do institutionals and insiders believe in LLIT or AEMD? 28.8% of Lianluo Smart shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 22.9% of Lianluo Smart shares are held by company insiders. Comparatively, 1.1% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is LLIT or AEMD more profitable? Lianluo Smart's return on equity of 0.00% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A Aethlon Medical N/A -141.89%-107.12% SummaryAethlon Medical beats Lianluo Smart on 7 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.37M$4.45B$5.39B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E RatioN/A38.29113.8115.12Price / Sales3.6065.071,483.2593.03Price / CashN/A49.1039.6434.05Price / Book-1.054.264.665.02Net Income-$4.45M$11.52M$119.06M$225.46M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$0.62+1.6%N/A+12.7%$1.37M$380,000.000.006AEMDAethlon Medical2.7883 of 5 stars$0.40+2.6%$7.00+1,650.4%-73.5%$5.56M$570,000.00-0.1010Analyst ForecastNews CoverageSTSSSharps Technology1.4723 of 5 stars$2.92-3.0%N/AN/A$5.26MN/A-0.283News CoverageINBSIntelligent Bio Solutions0.4469 of 5 stars$1.48-2.6%N/A-51.7%$4.61M$3.11M-0.0410News CoverageGap DownAFIBAcutus MedicalN/A$0.14flatN/A-69.4%$4.25M$7.16M0.00340INVOINVO BioscienceN/A$0.75-5.0%N/A-33.5%$2.87M$5.77M0.0025VEROVenus ConceptN/A$0.39+14.7%N/A-77.1%$2.83M$69.81M-0.05410Positive NewsGap UpHigh Trading VolumeRSLSReShape Lifesciences1.3531 of 5 stars$5.45-8.1%N/A-60.6%$2.78M$8.68M0.0050Positive NewsGap DownTNONTenon Medical0.6683 of 5 stars$3.26-6.6%$3.00-8.0%+4,306.6%$1.66M$2.93M-0.098News CoverageHigh Trading VolumeAVGRAvinger2.8848 of 5 stars$0.83flat$5.00+502.4%-77.7%$1.41M$7.43M-0.0770Upcoming EarningsAnalyst ForecastDYNTDynatronicsN/A$0.13+18.2%N/A-73.4%$816,000.00$33.60M-0.13200Analyst ForecastGap Down Related Companies and Tools Related Companies Aethlon Medical Competitors Sharps Technology Competitors Intelligent Bio Solutions Competitors Acutus Medical Competitors INVO Bioscience Competitors Venus Concept Competitors ReShape Lifesciences Competitors Tenon Medical Competitors Avinger Competitors Dynatronics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LLIT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
